最近审阅: 25 十月 2020
最近更新: 20 五月 2020

小结

详细信息

  • 甲状腺激素的产生
  • 甲状腺激素结合蛋白
  • 甲状腺功能测试的指标:总论
  • 已知的甲状腺功能失调及先前的观点
  • 妊娠期甲状腺功能障碍筛查
  • 甲状腺功能检查 (TFT)
  • 低TSH联合高FT4和/或FT3
  • 低TSH联合低FT4和/或FT3
  • 低TSH联合正常FT4和/或FT3
  • 高TSH联合高FT4和/或FT3
  • 高TSH联合低FT4和/或FT3
  • 高TSH联合正常FT4和/或FT3
  • 正常TSH联合低FT4和/或FT3
  • 药物的影响

撰稿人

Northeast Florida Endocrine & Diabetes Associates

Jacksonville

FL

利益声明

MS-A declares that she is a speaker for Novo Nordisk, AstraZeneca, Amgen, Merck, Eli Lilly, Abbott, AbbVie, MannKind, Valeritas, and Janssen. MS-A declares that none of these are related to this topic.

Dr Mae Sheikh-Ali would like to gratefully acknowledge Dr Harshit Shah, Dr Melanie Thomas, Dr Anna Szafran-Swietlik, Dr Sandra Mesliniene, Dr Emad Naem, and Dr Abdul-Razzak Alamir, previous contributors to this topic. HS, MT, AS-S, SM, EN, and A-RA declare that they have no competing interests.

同行评议者展开全部内容

Professor of Surgery

Virginia Commonwealth University

Richmond

VA

利益声明

RM declares that he has no competing interests.

Professor of Medicine and Endocrinology

Medical Center Spijkenisse

The Hague

The Netherlands

利益声明

Not disclosed.

Professor of Endocrinology

Newcastle University

Endocrine Unit

Royal Victoria Infirmary

Newcastle upon Tyne

UK

利益声明

SP declares that he has no competing interests.

Clinical Associate Professor of Medicine

Uniformed Services University of the Health Sciences

Bethesda

MD

MA and Senior Medical Advisor

NASA Headquarters

Washington

DC

利益声明

VSS declares that he has no competing interests.

内容使用需遵循免责声明